top of page
NemaLife YouTube Banner-2.png

NemaLife News

New Approaches for Incorporating Genetic Diversity into Toxicity Testing

  • Writer: NIH
    NIH
  • Jun 3, 2020
  • 1 min read

Our multi-prong approach is expected to de-risk drug failure in mammalian AD models. In summary, we will use a novel NemaLife technology to identify a subset of pharmacological longevity interventions will exert neuroprotection against AD-relevant stresses.


Comentarios


bottom of page